Balloon Dilation for Eustachian Tube Dysfunction
Trial Summary
What is the purpose of this trial?
This trial is testing a procedure called balloon dilation of the eustachian tube for adults with ear pressure problems that haven't improved with other treatments. The procedure uses a small balloon to widen the eustachian tube, helping it work better and reduce symptoms. Balloon dilation of the eustachian tube (BDET) is a commonly performed procedure.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it mentions that symptoms should persist despite using nasal steroid sprays or systemic steroids, suggesting you might continue these treatments if they are not effective.
What data supports the effectiveness of the treatment Balloon dilation of eustachian tube (Stryker XprESS LoProfile ENT dilation system)?
Is balloon dilation of the Eustachian tube safe for humans?
How is balloon dilation for Eustachian tube dysfunction different from other treatments?
Balloon dilation for Eustachian tube dysfunction is a minimally invasive procedure that uses a small balloon to open up the Eustachian tube, which is different from traditional treatments that may involve medication or more invasive surgery. This method is particularly useful for patients who do not respond to conventional therapies and offers a new option for a condition with limited treatment choices.13101112
Research Team
Justin Lui, MD, FRCSC
Principal Investigator
University of Calgary
Eligibility Criteria
This trial is for individuals with persistent eustachian tube dysfunction who haven't improved after using nasal sprays or decongestants, or those experiencing barotitis media symptoms regularly. Participants must have documented ear drum movement issues and a history of related symptoms like ear pain, pressure, hearing changes, tinnitus, or vertigo.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomly assigned to undergo either balloon dilation of the eustachian tube or a placebo procedure
Follow-up
Participants repeat assessments and questionnaires over four follow-up appointments at 6, 24, and 52 weeks after the procedure
Optional Crossover
Participants in the placebo group are offered the option to cross-over into the BDET group at 6 weeks post-procedure
Treatment Details
Interventions
- Balloon dilation of eustachian tube (Stryker XprESS LoProfile ENT dilation system)
- Sham procedure
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Calgary
Lead Sponsor